Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Andrésdóttir V[au]:

A supramolecular assembly mediates lentiviral DNA integration. Ballandras-Colas A et al. Science. (2017)

Maedi-visna virus persistence: Antigenic variation and latency. Arnarson H et al. Comp Immunol Microbiol Infect Dis. (2017)

Characterization of Ovine A3Z1 Restriction Properties against Small Ruminant Lentiviruses (SRLVs). de Pablo-Maiso L et al. Viruses. (2017)

Search results

Items: 48

1.

The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response.

Thorsteinsdóttir L, Jónsdóttir S, Stefánsdóttir SB, Andrésdóttir V, Wagner B, Marti E, Torsteinsdóttir S, Svansson V.

PLoS One. 2019 Jun 21;14(6):e0218576. doi: 10.1371/journal.pone.0218576. eCollection 2019.

2.

Characterization of Ovine A3Z1 Restriction Properties against Small Ruminant Lentiviruses (SRLVs).

de Pablo-Maiso L, Glaria I, Crespo H, Nistal-Villán E, Andrésdóttir V, de Andrés D, Amorena B, Reina R.

Viruses. 2017 Nov 17;9(11). pii: E345. doi: 10.3390/v9110345.

3.

Maedi-visna virus persistence: Antigenic variation and latency.

Arnarson H, Pálsson A, Gudnadóttir M, Andrésdóttir V.

Comp Immunol Microbiol Infect Dis. 2017 Dec;55:6-12. doi: 10.1016/j.cimid.2017.08.003. Epub 2017 Sep 8.

PMID:
29127994
4.

A supramolecular assembly mediates lentiviral DNA integration.

Ballandras-Colas A, Maskell DP, Serrao E, Locke J, Swuec P, Jónsson SR, Kotecha A, Cook NJ, Pye VE, Taylor IA, Andrésdóttir V, Engelman AN, Costa A, Cherepanov P.

Science. 2017 Jan 6;355(6320):93-95. doi: 10.1126/science.aah7002.

5.

Two mutations in the vif gene of maedi-visna virus have different phenotypes, indicating more than one function of Vif.

Franzdóttir SR, Ólafsdóttir K, Jónsson SR, Strobel H, Andrésson ÓS, Andrésdóttir V.

Virology. 2016 Jan 15;488:37-42. doi: 10.1016/j.virol.2015.10.035. Epub 2015 Nov 17.

6.

Lineage-Specific Viral Hijacking of Non-canonical E3 Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.

Kane JR, Stanley DJ, Hultquist JF, Johnson JR, Mietrach N, Binning JM, Jónsson SR, Barelier S, Newton BW, Johnson TL, Franks-Skiba KE, Li M, Brown WL, Gunnarsson HI, Adalbjornsdóttir A, Fraser JS, Harris RS, Andrésdóttir V, Gross JD, Krogan NJ.

Cell Rep. 2015 May 26;11(8):1236-50. doi: 10.1016/j.celrep.2015.04.038. Epub 2015 May 14.

7.

Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.

Jónsson SR, Andrésdóttir V.

Viruses. 2013 Jul 30;5(8):1934-47. doi: 10.3390/v5081934. Review.

8.

Propagating and detecting an infectious molecular clone of maedi-visna virus that expresses green fluorescent protein.

Jónsson SR, Andrésdóttir V.

J Vis Exp. 2011 Oct 9;(56). pii: 3483. doi: 10.3791/3483.

9.

Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.

Larue RS, Lengyel J, Jónsson SR, Andrésdóttir V, Harris RS.

J Virol. 2010 Aug;84(16):8193-201. doi: 10.1128/JVI.00685-10. Epub 2010 Jun 2.

10.

Construction and characterization of an infectious molecular clone of maedi-visna virus that expresses green fluorescent protein.

Gudmundsdóttir HS, Olafsdóttir K, Franzdóttir SR, Andrésdóttir V.

J Virol Methods. 2010 Sep;168(1-2):98-102. doi: 10.1016/j.jviromet.2010.04.026. Epub 2010 May 4.

PMID:
20447418
11.

Development and comparison of strain specific gag and pol real-time PCR assays for the detection of Visna/maedi virus.

Carrozza ML, Mazzei M, Bandecchi P, Fraisier C, Pérez M, Suzan-Monti M, de Andrés D, Amorena B, Rosati S, Andrésdottir V, Lujan L, Pepin M, Blacklaws B, Tolari F, Harkiss GD.

J Virol Methods. 2010 May;165(2):161-7. doi: 10.1016/j.jviromet.2010.01.013. Epub 2010 Jan 29.

PMID:
20116400
12.

Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus.

de Andrés X, Reina R, Ciriza J, Crespo H, Glaria I, Ramírez H, Grilló MJ, Pérez MM, Andrésdóttir V, Rosati S, Suzan-Monti M, Luján L, Blacklaws BA, Harkiss GD, de Andrés D, Amorena B.

Vaccine. 2009 Jul 23;27(34):4591-600. doi: 10.1016/j.vaccine.2009.05.080. Epub 2009 Jun 16.

PMID:
19538997
13.

Characterisation of an extracellular vibriolysin of the fish pathogen Moritella viscosa.

Bjornsdottir B, Fridjonsson OH, Magnusdottir S, Andresdottir V, Hreggvidsson GO, Gudmundsdottir BK.

Vet Microbiol. 2009 May 12;136(3-4):326-34. doi: 10.1016/j.vetmic.2008.11.020. Epub 2008 Dec 3.

PMID:
19147307
14.

The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.

LaRue RS, Jónsson SR, Silverstein KA, Lajoie M, Bertrand D, El-Mabrouk N, Hötzel I, Andrésdóttir V, Smith TP, Harris RS.

BMC Mol Biol. 2008 Nov 18;9:104. doi: 10.1186/1471-2199-9-104.

15.

Guidelines for naming nonprimate APOBEC3 genes and proteins.

LaRue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Greene WC, Jónsson SR, Landau NR, Löchelt M, Malik HS, Malim MH, Münk C, O'Brien SJ, Pathak VK, Strebel K, Wain-Hobson S, Yu XF, Yuhki N, Harris RS.

J Virol. 2009 Jan;83(2):494-7. doi: 10.1128/JVI.01976-08. Epub 2008 Nov 5. No abstract available.

16.

Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes.

Niesalla H, de Andrés X, Barbezange C, Fraisier C, Reina R, Arnarson H, Biescas E, Mazzei M, McNeilly TN, Liu C, Watkins C, Perez M, Carrozza ML, Bandecchi P, Solano C, Crespo H, Glaria I, Huard C, Shaw DJ, de Blas I, de Andrés D, Tolari F, Rosati S, Suzan-Monti M, Andrésdottir V, Torsteinsdottir S, Petursson G, Badiola J, Lujan L, Pepin M, Amorena B, Blacklaws B, Harkiss GD.

Vaccine. 2009 Jan 7;27(2):260-9. doi: 10.1016/j.vaccine.2008.10.042. Epub 2008 Nov 5.

PMID:
18984025
17.

The AsaP1 peptidase of Aeromonas salmonicida subsp. achromogenes is a highly conserved deuterolysin metalloprotease (family M35) and a major virulence factor.

Arnadottir H, Hvanndal I, Andresdottir V, Burr SE, Frey J, Gudmundsdottir BK.

J Bacteriol. 2009 Jan;191(1):403-10. doi: 10.1128/JB.00847-08. Epub 2008 Oct 24.

18.

Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes.

Reina R, Barbezange C, Niesalla H, de Andrés X, Arnarson H, Biescas E, Mazzei M, Fraisier C, McNeilly TN, Liu C, Perez M, Carrozza ML, Bandecchi P, Solano C, Crespo H, Glaria I, Huard C, Shaw DJ, de Blas I, de Andrés D, Tolari F, Rosati S, Suzan-Monti M, Andrésdottir V, Torsteinsdottir S, Petursson G, Lujan L, Pepin M, Amorena B, Blacklaws B, Harkiss GD.

Vaccine. 2008 Aug 18;26(35):4494-505. doi: 10.1016/j.vaccine.2008.06.065. Epub 2008 Jul 9.

PMID:
18606204
19.

Mutational analysis of a principal neutralization domain of visna/maedi virus envelope glycoprotein.

Haflidadóttir BS, Matthíasdóttir S, Agnarsdóttir G, Torsteinsdóttir S, Pétursson G, Andrésson OS, Andrésdóttir V.

J Gen Virol. 2008 Mar;89(Pt 3):716-21. doi: 10.1099/vir.0.83410-0.

PMID:
18272763
20.

The restriction of zoonotic PERV transmission by human APOBEC3G.

Jónsson SR, LaRue RS, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS.

PLoS One. 2007 Sep 12;2(9):e893.

21.

Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors.

Fraisier C, Arnarson H, Barbezange C, Andrésdŏttir V, Carrozza ML, De Andrés D, Tolari F, Rosati S, Luján L, Pépin M, Amorena B, Harkiss G, Blacklaws B, Suzan-Monti M.

J Virol Methods. 2007 Dec;146(1-2):363-7. Epub 2007 Aug 1.

PMID:
17675253
22.

Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence.

Oskarsson T, Hreggvidsdóttir HS, Agnarsdóttir G, Matthíasdóttir S, Ogmundsdóttir MH, Jónsson SR, Georgsson G, Ingvarsson S, Andrésson OS, Andrésdóttir V.

J Virol. 2007 Apr;81(8):4052-7. Epub 2007 Feb 7.

23.

Immune response to maedi-visna virus.

Torsteinsdottir S, Andresdottir V, Arnarson H, Petursson G.

Front Biosci. 2007 Jan 1;12:1532-43. Review.

PMID:
17127400
24.

Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins.

Jónsson SR, Haché G, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS.

Nucleic Acids Res. 2006;34(19):5683-94. Epub 2006 Oct 11.

25.

Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo.

Gudmundsson B, Jónsson SR, Olafsson O, Agnarsdóttir G, Matthíasdóttir S, Georgsson G, Torsteinsdóttir S, Svansson V, Kristbjornsdóttir HB, Franzdóttir SR, Andrésson OS, Andrésdóttir V.

J Virol. 2005 Dec;79(24):15038-42.

26.

Mucosal vaccination with an attenuated maedi-visna virus clone.

Pétursson G, Matthíasdóttir S, Svansson V, Andrésdóttir V, Georgsson G, Martin AH, Agnarsdóttir G, Gísladóttir E, Arnadóttir S, Högnadóttir S, Jónsson SR, Andrésson OS, Torsteinsdóttir S.

Vaccine. 2005 May 2;23(24):3223-8.

PMID:
15837223
27.

Cellular specificity and replication rate of Maedi Visna virus in vitro can be controlled by LTR sequences.

Barros SC, Andrésdóttir V, Fevereiro M.

Arch Virol. 2005 Feb;150(2):201-13. Epub 2004 Dec 21.

PMID:
15614437
28.

The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro.

Kristbjörnsdóttir HB, Andrésdóttir V, Svansson V, Torsteinsdóttir S, Matthíasdóttir S, Andrésson OS.

Virology. 2004 Jan 5;318(1):350-9.

29.

Evidence for recombination in the envelope gene of maedi-visna virus.

Andrésdóttir V.

Virus Genes. 2003 Aug;27(1):5-9.

PMID:
12913353
30.

Selection of antigenic variants in maedi-visna virus infection.

Andrésdóttir V, Skraban R, Matthíasdóttir S, Lutley R, Agnarsdóttir G, Thorsteinsdóttir H.

J Gen Virol. 2002 Oct;83(Pt 10):2543-51.

PMID:
12237438
31.

The long terminal repeat is a determinant of cell tropism of maedi-visna virus.

Agnarsdóttir G, Thorsteinsdóttir H, Oskarsson T, Matthíasdóttir S, Haflidadóttir BS, Andrésson OS, Andrésdóttir V.

J Gen Virol. 2000 Aug;81(Pt 8):1901-5.

PMID:
10900026
32.

Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype.

Skraban R, Matthíasdóttir S, Torsteinsdóttir S, Agnarsdóttir G, Gudmundsson B, Georgsson G, Meloen RH, Andrésson OS, Staskus KA, Thormar H, Andrésdóttir V.

J Virol. 1999 Oct;73(10):8064-72.

33.

Constitutive and visna virus induced expression of class I and II major histocompatibility complex antigens in the central nervous system of sheep and their role in the pathogenesis of visna lesions.

Bergsteinsdóttir K, Arnadóttir S, Torsteinsdóttir S, Agnarsdóttir G, Andrésdóttir V, Péttursson G, Georgsson G.

Neuropathol Appl Neurobiol. 1998 Jun;24(3):224-32.

PMID:
9717188
34.

Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus.

Andrésdóttir V, Tang X, Agnarsdóttir G, Andrésson OS, Georgsson G, Skraban R, Torsteinsdóttir S, Rafnar B, Benediktsdóttir E, Matthíasdóttir S, Arnadóttir S, Högnadóttir S, Pálsson PA, Pétursson G.

Virus Genes. 1998;16(3):281-93.

PMID:
9654682
35.

Visna virus dUTPase is dispensable for neuropathogenicity.

Pétursson G, Turelli P, Matthíasdóttir S, Georgsson G, Andrésson OS, Torsteinsdóttir S, Vigne R, Andrésdóttir V, Gunnarsson E, Agnarsdóttir G, Quérat G.

J Virol. 1998 Feb;72(2):1657-61.

36.

In vivo and in vitro infection with two different molecular clones of visna virus.

Torsteinsdóttir S, Agnarsdóttir G, Matthíasdóttir S, Rafnar B, Andrésdóttir V, Andrésson OS, Staskus K, Pétursson G, Pálsson PA, Georgsson G.

Virology. 1997 Mar 17;229(2):370-80.

37.

Renibacterium salmoninarum, the causative agent of bacterial kidney disease in salmonid fish, detected by nested reverse transcription-PCR of 16S rRNA sequences.

Magnússon HB, Fridjónsson OH, Andrésson OS, Benediktsdóttir E, Gudmundsdóttir S, Andrésdóttir V.

Appl Environ Microbiol. 1994 Dec;60(12):4580-3.

38.

Sequence variation in the envelope gene and the LTR of maedi-visna virus.

Andrésdóttir V, Tang X, Andrésson OS, Georgsson G.

Ann N Y Acad Sci. 1994 Jun 6;724:157-8. No abstract available.

PMID:
8030935
39.

Pathogenic proviral molecular clone of neurovirulent visna virus.

Andrésson OS, Elser JE, Georgsson G, Tobin GJ, Greenwood JD, Gonda MA, Andrésdóttir V, Pálsson PA, Pétursson G.

Ann N Y Acad Sci. 1994 Jun 6;724:133-9. Review. No abstract available.

PMID:
8030932
40.

Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus.

Andrésson OS, Elser JE, Tobin GJ, Greenwood JD, Gonda MA, Georgsson G, Andrésdóttir V, Benediktsdóttir E, Carlsdóttir HM, Mäntylä EO.

Virology. 1993 Mar;193(1):89-105.

PMID:
8382414
41.

Human and ovine lentiviral infections compared.

Pétursson G, Andrésdóttir V, Andrésson O, Torsteinsdóttir S, Georgsson G, Pálsson PA.

Comp Immunol Microbiol Infect Dis. 1991;14(4):277-87. Review.

PMID:
1684142
42.

[Visna and AIDS--various comparative aspects].

Georgsson G, Andrésdóttir V, Pálsson PA, Pétursson G.

Nord Med. 1991;106(4):112-5. Review. Danish.

PMID:
1645467
43.

Subclasses of IgG from whales.

Andrésdóttir V, Magnadóttir B, Andrésson OS, Pétursson G.

Dev Comp Immunol. 1987 Fall;11(4):801-6. No abstract available.

PMID:
3126089
44.

Catabolite repressive effects of 5-thio-D-glucose on Saccharomyces cerevisiae.

Egilsson V, Gudnason V, Jónasdottir A, Ingvarsson S, Andresdottir V.

J Gen Microbiol. 1986 Dec;132(12):3309-13.

PMID:
3309135
46.

Isoenzyme pattern and subcellular localization of hexokinases in human breast cancer and nonpathological breast tissue.

Gudnason V, Ingvarsson S, Jonasdottir A, Andresdottir V, Egilsson V.

Int J Cancer. 1984 Jul 15;34(1):63-6.

PMID:
6746120
47.

Plasmids carrying oriC can integrate at or near the chromosome origin of Escherichia coli in the absence of a functional recA product.

Masters M, Andresdottir V, Wolf-Watz H.

Cold Spring Harb Symp Quant Biol. 1979;43 Pt 2:1069-72. No abstract available.

PMID:
385219
48.

Evidence that F' lac replicates asynchronously during the cell cycle of Escherichia coli B/r.

Andresdottir V, Masters M.

Mol Gen Genet. 1978 Jul 11;163(2):205-12.

PMID:
98704

Supplemental Content

Loading ...
Support Center